Dr. Mani is a healthcare professional with over 24 years of experience in the pharmaceutical industry. He most recently served as the President & CEO for Kesin Pharma Corporation, a Specialty Pharma company. His past experiences include serving as the CEO of Xiromed LLC, a Generics and Specialty drug product company and an affiliate of the Insud Pharma Group based in Madrid, Spain. His immediate role prior to Xiromed was as the VP, Global Corp Strategy and BD, at Amneal Pharmaceuticals where he led all the company’s strategic initiatives across Global Strategy, Portfolio Management, Business Development and Commercial Operations. His previous experiences also include being the Corporate Finance and Strategic Planning Leader at Johnson & Johnson in New Brunswick, NJ in the pharmaceutical and medical device sectors. Dr. Mani holds a B.S. in Pharmaceutical Sciences from BITS, Pilani, India and a M.S. Analytical Chemistry, from the University of Oklahoma. Further studies include a Ph.D. in Pharmaceutics, from the University of Georgia and MBA in Finance and Marketing from Columbia Business School.